Home / Drug shortages / Insulin Degludec Injection

Insulin Degludec Injection — FDA Drug Shortage

To Be Discontinued — Novo Nordisk, Inc.

The FDA lists a drug shortage record for Insulin Degludec Injection (injection) from Novo Nordisk, Inc. with status To Be Discontinued. The shortage was first posted on 07/21/2025.

Shortage Details

Status
To Be Discontinued
Company
Novo Nordisk, Inc.
Package NDC
73070-503-15
Dosage Form
Injection
Presentation
Insulin Degludec, Injection, 3 mL Insulin Degludec 200 units/mL (U-200) FlexTouch® (NDC 73070-503-15)
Initial Posting
07/21/2025
Revised Date

FDA data resources